Generics 28

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cilastatin manufacturers

28 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

28 products found

imipenem monohydrate + cilastatin

Injection 500 mg+500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19464
This company is a leading generic pharmaceutical manufacturer with over six decades of experience. They produce a wide range of products, including prescription medications, over-the-counter drugs, injectables, liquids, and external preparations. Their therapeutic areas include antibiotics, anti-diabetics, anti-malarials, NSAIDs, cardiology medications, central nervous system drugs, gastrointestinal agents, hormones, respiratory/anti-allergic medications, urology/infertility treatments, and health supplements. The company holds various certifications including ISO 9001, ISO 15378, GMP, WHO-GMP, and FSSAI. They export their products to over 30 countries across the globe, with a significant portion of their turnover coming from international operations. They emphasize quality assurance through rigorous testing and analysis at various stages of product development and manufacturing.

Manufacturer usually replies in 3 days

imipenem + cilastatin

Vials 250 mg + 250 mg, 500 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #12792
This company focuses on nurturing healthy living through a range of pharmaceutical products aiding in disease treatment and prevention. They offer branded formulations, specialty generics, injectables, vaccines, and biologics across various therapy areas. Key product lines include prescription medications, over-the-counter drugs, and vaccines targeting diseases like Hepatitis B, Covid-19, Diphtheria, Tetanus, Pertussis, and Japanese Encephalitis. Principal dosage forms include injections and oral formulations. The company operates in regions like the EU and North America, adhering to strict GMP certifications for quality assurance. They also hold patents for specific products, highlighting their commitment to innovation.

Manufacturer usually replies in 6 days

imipenem + cilastatin

Injection 250 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21424
This multinational conglomerate operates a biopharmaceutical company that holds accreditation in over 25 countries. The company focuses on developing and manufacturing prescription medications across several key therapy areas, including diabetes. They produce a wide range of dosage forms, adhering to strict GMP certifications. The company's products are distributed globally within regions like North America, the EU, and beyond. They emphasize quality control, efficient production processes, and building trust with clients through fair business practices.

Manufacturer usually replies in 13 days

Want to see all 28 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible